Jussi P. Elo - Concepedia

Author

Jussi P. Elo

University of Oulu

Also Known As

J Elö, J P Elo, Jussi Elo, Jussi P Elo, Jussi P. Elo

Publications

924

Citations

H-Index

Concepts

All Affiliations

University of Oulu Tampere University Hospital Biocenter Finland

About

Jussi P. Elo is an author at University of Oulu specializing in medicine, urology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	565
2	Biochemistry	1	1	69
3	Cell Biology	1	1	267
4	Endocrinology	1	1	69
5	Immunology	1	1	267

Jussi P. Elo

Publications

792

Citations

H-Index

Page 1

	Year	Citations
Characterization of a novel cell line established from a patient with Herceptin-resistant breast cancer Minna Tanner, Anita I. Kapanen, Teemu T. Junttila, Molecular Cancer Therapeutics Tumor BiologyBreast OncologyNovel Cell LineClinical ResistanceHerceptin-resistant Breast Cancer	2004	267
Genomewide DNA hypomethylation is associated with alterations on chromosome 8 in prostate carcinoma Wolfgang A. Schulz, Jussi P. Elo, Andrea R. Florl, Genes Chromosomes and Cancer	2002	163
Mutated human androgen receptor gene detected in a prostatic cancer patient is also activated by estradiol. Jussi P. Elo, Linda J. Kvist, Katri A. Leinonen, The Journal of Clinical Endocrinology & Metabolism UrologySomatic VariantProstatic CancerPoint MutationsHormonal Receptor	1995	136
Loss of heterozygosity at 16q24.1-q24.2 is significantly associated with metastatic and aggressive behavior of prostate cancer. Jussi P. Elo, Pirjo Härkönen, Atte P. Kyllönen, PubMed Tumor BiologyDisease HeterogeneityUrologyCancer PathologyGenitourinary Cancer	1997	93
Characterization of 17B‐hydroxysteroid dehydrogenase isoenzyme expression in benign and malignant human prostate Jussi P. Elo, Lateef Akinola, Matti Poutanen, International Journal of Cancer Androgen ReceptorDehydrogenase Isoenzyme ExpressionUrologyMalignant Human ProstateBiochemistry	1996	69
Three independently deleted regions at chromosome arm 16q in human prostate cancer: allelic loss at 16q24.1–q24.2 is associated with aggressive behaviour of the disease, recurrent growth, poor differentiation of the tumour and poor prognosis for the patient Jussi P. Elo, Pirjo Härkönen, Atte P. Kyllönen, British Journal of Cancer	1998	52
The Elimination of Transfer Distances Is an Important Part of Hospital Design Sauli Karvonen, Isto Nordback, Jussi P. Elo, HERD Health Environments Research & Design Journal	2016	12

Page 1